2014 Oncology Research Grant
RESEARCH TRIANGLE PARK, NC – August 19, 2014 – Expression Analysis (EA), a Quintiles company, today announced that it is co-sponsoring a grant program that provides scientists with leading-edge products and services to advance genomics research. In the sixth year of the grant program, EA and co-sponsor, Illumina, will award two fully funded oncology research grants. Each grant will enable winners to investigate genomic data locked within Formalin-Fixed, Paraffin Embedded (FFPE) tumor samples - focusing on a largely untapped data pool in an effort to enhance researchers’ understanding of cancer biology.» Read More
Since its founding in 1982, Quintiles has become a leading clinical research organization, from first-in-human studies to post-launch monitoring. In 2013, Quintiles acquired Expression Analysis (EA) to expand its genomic testing analysis services throughout the entire process of drug discovery and development.
Dr. Patrick Hurban, a trained molecular biologist and geneticist and EA’s Global Head of Genomic R&D, tells Nature how the marriage between EA and Quintiles benefits researchers.» Read more